GB9705903D0 - VP22 Proteins and uses thereof - Google Patents

VP22 Proteins and uses thereof

Info

Publication number
GB9705903D0
GB9705903D0 GBGB9705903.4A GB9705903A GB9705903D0 GB 9705903 D0 GB9705903 D0 GB 9705903D0 GB 9705903 A GB9705903 A GB 9705903A GB 9705903 D0 GB9705903 D0 GB 9705903D0
Authority
GB
United Kingdom
Prior art keywords
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9705903.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ELLIOTT GILLIAN D
Original Assignee
ELLIOTT GILLIAN D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ELLIOTT GILLIAN D filed Critical ELLIOTT GILLIAN D
Priority to GBGB9705903.4A priority Critical patent/GB9705903D0/en
Publication of GB9705903D0 publication Critical patent/GB9705903D0/en
Priority to JP54522798A priority patent/JP2001520521A/ja
Priority to PCT/GB1998/000873 priority patent/WO1998042742A1/en
Priority to AU67393/98A priority patent/AU6739398A/en
Priority to US09/381,211 priority patent/US20020128174A1/en
Priority to CA002283794A priority patent/CA2283794A1/en
Priority to EP98912613A priority patent/EP0971953A1/en
Priority to US10/617,910 priority patent/US7067632B2/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GBGB9705903.4A 1997-03-21 1997-03-21 VP22 Proteins and uses thereof Pending GB9705903D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9705903.4A GB9705903D0 (en) 1997-03-21 1997-03-21 VP22 Proteins and uses thereof
JP54522798A JP2001520521A (ja) 1997-03-21 1998-03-23 Ｖｐ２２タンパク質及びその使用
PCT/GB1998/000873 WO1998042742A1 (en) 1997-03-21 1998-03-23 Vp22 proteins and uses thereof
AU67393/98A AU6739398A (en) 1997-03-21 1998-03-23 Vp22 proteins and uses thereof
US09/381,211 US20020128174A1 (en) 1997-03-21 1998-03-23 Vp22 proteins and uses thereof
CA002283794A CA2283794A1 (en) 1997-03-21 1998-03-23 Vp22 proteins and uses thereof
EP98912613A EP0971953A1 (en) 1997-03-21 1998-03-23 Vp22 proteins and uses thereof
US10/617,910 US7067632B2 (en) 1997-03-21 2003-07-10 VP22 proteins and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9705903.4A GB9705903D0 (en) 1997-03-21 1997-03-21 VP22 Proteins and uses thereof

Publications (1)

Publication Number Publication Date
GB9705903D0 true GB9705903D0 (en) 1997-05-07

Family

ID=10809645

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9705903.4A Pending GB9705903D0 (en) 1997-03-21 1997-03-21 VP22 Proteins and uses thereof

Country Status (7)

Country Link
US (2) US20020128174A1 (https=)
EP (1) EP0971953A1 (https=)
JP (1) JP2001520521A (https=)
AU (1) AU6739398A (https=)
CA (1) CA2283794A1 (https=)
GB (1) GB9705903D0 (https=)
WO (1) WO1998042742A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423334B1 (en) 1997-10-01 2002-07-23 Elan Corporation, Plc Composition and method for enhancing transport across gastrointestinal tract cell layers

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9816761D0 (en) 1998-07-31 1998-09-30 Phogen Limited Herpesvirus preparations and their uses
DE60040274D1 (de) * 1999-03-10 2008-10-30 Phogen Ltd Verabreichung von nukleinsäuren und proteinen an zellen
US6358739B1 (en) 1999-04-12 2002-03-19 Modex Therapeutiques, S.A. Transiently immortalized cells
US6451601B1 (en) 1999-04-12 2002-09-17 Modex Therapeutiques, S.A. Transiently immortalized cells for use in gene therapy
GB9930519D0 (en) * 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins
US6688084B2 (en) * 2000-03-24 2004-02-10 International Paper Company Automated bulk box strapper
BRPI0406647A (pt) * 2003-01-06 2005-12-06 Angiochem Inc Método para transportar um composto através da barreira sanguìnea do cérebro
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
TR201905480T4 (tr) 2008-04-18 2019-05-21 Angiochem Inc Paklitaksel, paklitaksel analogları veya paklitaksel konjugatlarının farmasötik bileşimleri ve ilgili preparasyon ve kullanım yöntemleri.
MX2011004019A (es) 2008-10-15 2011-06-24 Angiochem Inc Conjugados de etoposido y doxorubicina para entrega de farmacos.
BRPI0920209A2 (pt) 2008-10-15 2015-12-22 Angiochem Inc conjugados de agonistas de glp-1 e usos dos mesmos
CA2745524C (en) 2008-12-05 2020-06-09 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
WO2010069074A1 (en) 2008-12-17 2010-06-24 Universite Du Quebec A Montreal Membrane type-1 matrix metalloprotein inhibitors and uses thereof
WO2010121379A1 (en) 2009-04-20 2010-10-28 Angiochem Inc Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
AU2010268726A1 (en) 2009-07-02 2012-01-19 Angiochem Inc. Multimeric peptide conjugates and uses thereof
DK3307326T3 (da) 2015-06-15 2020-10-19 Angiochem Inc Fremgangsmåder til behandling af leptomeningeal karcinomatose

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5278324A (en) 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5059699A (en) 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
TW223634B (https=) 1991-03-18 1994-05-11 Kingston David G I
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
CA2128693A1 (en) 1992-01-31 1993-08-05 Peter B. Schiff Taxol as a radiation sensitizer
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
CA2086874E (en) 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
US5631278A (en) 1992-12-02 1997-05-20 Thomas Jefferson University Methods of killing protozoal parasites
US5356927A (en) 1992-12-02 1994-10-18 Thomas Jefferson University Methods of treating plasmodium and babesia parasitic infections
US5583153A (en) * 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
BR9610058A (pt) * 1995-07-28 1999-07-27 Marie Curie Cancer Care Uso de vp22 ou uma porção ativa fragmento ou homólogo do mesmo proteína de transporte ácido nucleíco vetor de expressão célula hospedeira de mamíferos ou microbiana e processos para transportar uma proteína ou peptídeo desejado para uma população de marcaç o de células e para transportar uma molécula desejada em uma população de células
US6017735A (en) * 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423334B1 (en) 1997-10-01 2002-07-23 Elan Corporation, Plc Composition and method for enhancing transport across gastrointestinal tract cell layers

Also Published As

Publication number Publication date
US7067632B2 (en) 2006-06-27
JP2001520521A (ja) 2001-10-30
US20020128174A1 (en) 2002-09-12
EP0971953A1 (en) 2000-01-19
US20050118717A1 (en) 2005-06-02
CA2283794A1 (en) 1998-10-01
WO1998042742A1 (en) 1998-10-01
AU6739398A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
AU6241698A (en) Tace-like and matrilysin-like polypeptides
HUP0200414A2 (en) Interferon-betha fusion proteins and uses
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
AU9781998A (en) Huchordin and uses thereof
GB9705903D0 (en) VP22 Proteins and uses thereof
GB9806806D0 (en) Peptides and uses thereof
EP1015474A4 (en) DON-1 GENE, POLYPEPTIDES AND USES THEREOF
ZA9710338B (en) Proteins
IL133582A0 (en) Mammalian neuro-growth factor like protein
IL128570A0 (en) Protein kinases and uses thereof
ZA984322B (en) Sucrose-binding proteins
GB9701710D0 (en) Mammalian protein
GB9423372D0 (en) Proteins and their uses
AUPN024994A0 (en) Assay and peptides for use therein
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
IL115317A0 (en) Proteins
GB2336844B (en) Anti-hiv peptides and proteins
PL341293A1 (en) Beta-lypothropin and application thereof
AU6160598A (en) Differentiation enhancing factors and uses therefor
ZA971900B (en) Modified proteins
IL136693A0 (en) V196 dna and polypeptides
IL120392A0 (en) Novel PKA-binding proteins and uses thereof
IL120413A0 (en) Novel PKA-binding proteins and uses thereof
IL136620A0 (en) Tigirr dna and polypeptides
GB9703104D0 (en) Proteins